KAREN FULWOOD: Open Payments
NPI 1164414520 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,927 in 180 payments from 14 companies in 2025. Trend: 2023 $9,500 · 2024 $5,012 · 2025 $7,927
Food & beverage: $4,164Speaker / faculty: $3,600Travel & lodging: $163
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $4,421 |
| Otsuka America Pharmaceutical, Inc. | 19 | $588 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $518 |
| Alkermes, Inc. | 16 | $513 |
| Vanda Pharmaceuticals Inc. | 14 | $418 |
| Neurocrine BioSciences, Inc. | 12 | $295 |
| Axsome Therapeutics, Inc. | 14 | $281 |
| E.R. Squibb & Sons, L.L.C. | 13 | $274 |
| Teva Pharmaceuticals USA, Inc. | 13 | $242 |
| Janssen Pharmaceuticals, Inc | 4 | $205 |
Products named: VRAYLAR, REXULTI, CAPLYTA, ARISTADA, HETLIOZ, INGREZZA, COBENFY, Auvelity.
Industry payments across SC — which companies pay providers there.
